Log in to search using one of your social media accounts:

 

FDA Approves First Adjuvant Therapy for Renal Cell Carcinoma
The FDA has approved sunitinib malate (Sutent) as an adjuvant therapy for adults at risk for recurrent renal cell carcinoma following nephrectomy. Sunitinib, a kinase... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 20, 2017 Category: Primary Care Source Type: news

FDA Approves Adjuvant Sunitinib for High-Risk RCC
The FDA has approved sunitinib (Sutent) for use as an adjuvant therapy in patients with renal cell carcinoma (RCC) who have received nephrectomy and are high risk for recurrence.11/30/2017 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - November 19, 2017 Category: Urology & Nephrology Source Type: news

Pfizer receives FDA approval for SUTENT ® (sunitinib malate) as first and only adjuvant treatment for adult patients at high risk of recurrent renal cell carcinoma
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy (surgical removal of the cancerous kidney). (Source: World Pharma News)
Source: World Pharma News - November 16, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Robotic Radical Nephrectomy Becoming More Common
And robotic laparoscopy for rectal cancer resection does not reduce risk for conversion to open surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 26, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Nephrology, Oncology, Surgery, Journal, Source Type: news

Sunitinib Has No Survival Benefit in Renal-cell Carcinoma, May Limit Late Recurrence Sunitinib Has No Survival Benefit in Renal-cell Carcinoma, May Limit Late Recurrence
Adjuvant treatment of renal-cell carcinoma (RCC) after nephrectomy with sunitinib has produced no increase in overall survival, but the treatment results in less distant disease recurrence and a higher rate of disease-free survival, according to the latest data from the S-TRAC study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 5, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Positive Surgical Margins in RCC More Common Among African Americans
African American patients with localized renal cell carcinoma who underwent robotic partial nephrectomy were at an increased risk for positive surgical margins compared with white patients. (Source: CancerNetwork)
Source: CancerNetwork - August 14, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news

Could SBRT Have Role in Metastatic Kidney Cancer?
This video examines a pilot trial that tested stereotactic body radiotherapy plus nephrectomy in patients with renal cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - June 28, 2017 Category: Cancer & Oncology Authors: Thomas Schwaab, MD, PhD Tags: News Renal Cell Carcinoma Videos Genitourinary Cancers Source Type: news

1 out of 200 kidney surgery recipients DIE in just 30 days after the procedure, new study warns
(Natural News) A recent analysis published in the journal BJU International revealed that all forms of kidney surgery were associated with a slight increase in 30-day mortality. As part of the study, a team of British researchers pooled data from the British Association of Urological Surgeons National Nephrectomy Audit with a total cohort population of more than 21,000 kidney... (Source: NaturalNews.com)
Source: NaturalNews.com - May 13, 2017 Category: Consumer Health News Source Type: news

Analysis examines mortality risks after different types of kidney surgery
(Wiley) A new study provides insights into the true risks of all types of nephrectomy, or surgical removal of the kidney. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 5, 2017 Category: Global & Universal Source Type: news

Your participation in this research project can help ensure that the company ’s brochure and other materials are relevant to patients
A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients.Your participation in this research project can help ensure that the company’s brochure and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way.Fieldwork, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf. The research project consists of a one-time telephone interview lasting 60 minutes....
Source: Kidney Cancer Association - February 23, 2017 Category: Urology & Nephrology Source Type: news

Nephrectomy (kidney removal)
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - February 8, 2017 Category: Consumer Health News Source Type: news

The Contemporary Role of Radical Nephrectomy for RCC The Contemporary Role of Radical Nephrectomy for RCC
This study examined the role of tumor size and histological characteristics to determine when sampling is warranted.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nephrectomy, Hepatic Resection Possible Safe Aggressive Approach for RCC
Patients with RCC who underwent simultaneous nephrectomy and hepatic resection had similar postoperative mortality, long-term survival, and cancer-specific survival as those patients who underwent metastasectomy or en bloc resection of neighboring non-hepatic organs. (Source: CancerNetwork)
Source: CancerNetwork - September 5, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news

Rethinking Cytoreductive Nephrectomy in Metastatic RCC Rethinking Cytoreductive Nephrectomy in Metastatic RCC
Recent data suggest that cytoreductive nephrectomy may confer a significant survival advantage in metastatic renal cell carcinoma.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 24, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

' Alarming' Decrease in Survival as Surgery Underused in mRCC'Alarming' Decrease in Survival as Surgery Underused in mRCC
Cytoreductive nephrectomy in patients with metastatic renal cancer has been underutilized since the advent of targeted therapy, despite lack of hard evidence that survival is not adversely affected.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 19, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study examines different types of surgery for kidney cancer
For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study.08/02/2016 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 2, 2016 Category: Urology & Nephrology Source Type: news

Study examines different types of surgery for kidney cancer
(Wiley) For completely endophytic kidney tumors, which grow inward, both open partial nephrectomy (OPN) and robotic partial nephrectomy (RPN) led to excellent patient outcomes in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2016 Category: Global & Universal Source Type: news

Nephrectomy for RCC May Result in Significant Declines in Renal Function
Patients with RCC had greater postsurgical decreases in kidney function compared with patients with upper tract urothelial carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - July 28, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Genitourinary Cancers News Renal Cell Carcinoma Source Type: news

Study finds surgery can lengthen survival of metastatic kidney cancer patients
(Dana-Farber Cancer Institute) Researchers find cytoreductive nephrectomy may offer an overall survival benefit to patients with metastatic kidney cancer who are treated with targeted therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 20, 2016 Category: Cancer & Oncology Source Type: news

Patients Needed for Research Project
A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients. Your participation in this research project can help ensure that the company’s website and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way. Flince Research + Design, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf.   The research proje...
Source: Kidney Cancer Association - March 15, 2016 Category: Urology & Nephrology Source Type: news

H3K36me3 and Risk of Renal Cell Carcinoma-Specific DeathH3K36me3 and Risk of Renal Cell Carcinoma-Specific Death
This study suggests H3K36me3 expression may be useful as a prognostic biomarker post-nephrectomy for clear cell renal carcinoma. Modern Pathology (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 18, 2016 Category: Pathology Tags: Pathology & Lab Medicine Journal Article Source Type: news

Removal of complex renal tumors performed safely by robotic surgery in selected patients
(Elsevier Health Sciences) Renal cell carcinoma can sometimes spread to the inferior vena cava (IVC), the body's largest vein, posing a threat to the heart and brain. Robotic nephrectomy for inferior vena cava tumor thrombus has favorable outcomes in selected patients compared with open surgery, which can have a high rate of complications, report surgeons in The Journal of Urology®. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2016 Category: Cancer & Oncology Source Type: news

Titan Medical debuts Sport robot assisted surgery prototype
Titan Medical (CVE:TMD) yesterday introduced the prototype of its Sport robot-assisted surgery device to investors in New York as it gears up for 1st-in-human trials this year. Titan is chasing TransEnterix (NYSE:TRXC) in the race to challenge robot-assisted surgery’s dominant player, Intuitive Surgical (NSDQ:ISRG), and its da Vinci system. TransEnterix’s SurgiBot is expected to hit the U.S. market during the 1st half of this year; Titan’s Sport offering is anticipated for mid-2017. Late-comers to the space include the Verb joint venture between Johnson & Johnson (NYSE:JNJ) and Goo...
Source: Mass Device - January 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Robot-Assisted Surgery Wall Street Beat Intuitive Surgical Inc. Titan Medical Inc. Source Type: news

First of its kind robotic-assisted surgery makes cover of Urology
Physicians at Upstate Medical University highlight complex case involving nephrectomy, thrombectomy and lymph node removal with robotic assistance in Urology. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - January 19, 2016 Category: Universities & Medical Training Source Type: news

Tumor Burden Postsurgery Not Predictive of Survival in mRCCTumor Burden Postsurgery Not Predictive of Survival in mRCC
Using three-dimensional volumetric measurements, higher primary tumor burden was not associated with poor overall survival in patients with mRCC who underwent cytoreductive nephrectomy. Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 9, 2015 Category: Radiology Tags: Hematology-Oncology News Source Type: news

2015 Conquer Cancer Foundation of ASCO Young Investigator Award Funded by Kidney Cancer Association
Matthew Campbell, MD Chief Fellow, Hematology/Oncology Fellowship, UT MD Anderson Cancer Center New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the ...
Source: Kidney Cancer Association - May 11, 2015 Category: Cancer & Oncology Source Type: news

Analysis of Gene Expression of RCC by DNA Microaray in Patients treated with Sunitinib
Gene Evaluation of DNA expression from snap-frozen renal cell cancer tissue from 5 patients with locally advanced non-metastatic tumors, submitted to nephrectomy after being treated with 2 cycles of neoadjuvant Sunitinib...05/11/2015 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - May 11, 2015 Category: Cancer & Oncology Source Type: news

2015 Conquer Cancer Foundation of ASCO Young Investigator Award
Layperson Summary  New agents called immune check point inhibitors have been FDA approved in the treatment of metastatic melanoma and metastatic squamous cell lung cancer. These agents have shown exciting activity in bladder, kidney, and a variety of other cancers in early clinical studies and are being explored in larger studies. The first of these agents, ipilimumab, is an antibody that binds to CTLA-4, a molecule that is increased by T cells responding to a stimulus, to help shut off the immune response. When the anti-body binds to CTLA-4, the immune system is able to stay activated an...
Source: Kidney Cancer Association - May 10, 2015 Category: Cancer & Oncology Source Type: news

New Study Finds That Robotically Assisted Surgery For Kidney Cancer Increases Access To Partial Versus Radical Nephrectomy, Reducing Mortality, Renal Failure And Long-Term Costs
A new study, published in the February issue of Health Affairs, found that in terms of quality-adjusted life-years gained, the benefits of robotic-assisted partial nephrectomy surgery for kidney cancer patients outweighed the health care and surgical costs to patients and payers by a ratio of five to one. (Source: Medical Design Online News)
Source: Medical Design Online News - February 6, 2015 Category: Medical Equipment Source Type: news

Patients with operable kidney cancers more likely to have partial nephrectom
Patients with operable kidney cancers were more likely to have a partial nephrectomy -- the recommended treatment for localized tumors -- when treated in hospitals that were early adopters of robotic surgery, according to a new study.12/15/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - December 15, 2014 Category: Cancer & Oncology Source Type: news

Early adoption of robotic surgery leads to organ preservation for kidney cancer patients
Researchers found that partial nephrectomy -- the recommended treatment for localized kidney tumors -- was performed more frequently at hospitals that were early adopters of robotic surgery. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 11, 2014 Category: Science Source Type: news

Surgical robot adopters use more of recommended procedure for kidney cancer, reports Medical Care
(Wolters Kluwer Health) Hospitals with robotic surgical systems are more likely to perform 'nephron-sparing' partial nephrectomy -- a recommended alternative to removal of the entire kidney -- in patients with kidney cancer, reports a study in the December issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2014 Category: Global & Universal Source Type: news

Early adoption of robotic surgery leads to organ preservation for kidney cancer patients
(NYU Langone Medical Center / New York University School of Medicine) Researchers at NYU Langone Medical Center conclude that patients with operable kidney tumors were more likely to undergo a partial nephrectomy -- the recommended course of treatment -- at hospitals that were early adopters of robotic surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 11, 2014 Category: Cancer & Oncology Source Type: news

Robotic Radical Nephrectomy for Renal Cell CarcinomaRobotic Radical Nephrectomy for Renal Cell Carcinoma
Robotic radical nephrectomy for the treatment of RCC, while effective, does not offer any advantages over the laparoscopic technique, according to a new study. BMC Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 4, 2014 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Adjuvant Therapy for RCC
At the present time, the standard of care for patients who have received nephrectomy for localized renal cell carcinoma (RCC) is radiographic surveillance.09/05/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - September 5, 2014 Category: Cancer & Oncology Source Type: news

Extremely delayed brain metastasis from renal cell carcinoma
Brain metastasis occurs in 3.9-24% of patients with renal cell carcinoma (RCC), with an average interval from nephrectomy to brain metastasis of 1 to 3 years.08/15/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - August 15, 2014 Category: Cancer & Oncology Source Type: news

Partial nephrectomy retains edge over radical nephrectomy in larger renal tumors
Patients with renal cell carcinoma tumours larger than 4 cm benefit from undergoing elective partial nephrectomy (PN) rather than radical nephrectomy (RN) surgery, a study has found.07/24/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 24, 2014 Category: Cancer & Oncology Source Type: news

Cytoreductive nephrectomy can benefit patients with mRCC
Patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC) may derive significant survival benefit from cytoreductive nephrectomy (CN), particularly if their initial prognosis is good, study findings indicate.07/24/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 24, 2014 Category: Cancer & Oncology Source Type: news

Robot-assisted technique improves surgeons' ability to remove small kidney cancer tumors
Roughly 50,000 Americans are diagnosed with kidney cancer each year. Most of them have small tumors that doctors discover while screening for other health problems. The surgeries to remove renal tumors can be difficult, particularly if the cancer is on the posterior side of the kidney and if patients have had previous abdominal surgery, because scar tissue from previous operations usually makes it hard for surgeons to distinguish the normal parts of the body from one another. Now, a study led by Dr. Jim Hu and researchers at UCLA's Jonsson Comprehensive Cancer Center has shown that a newer surgical technique called ro...
Source: UCLA Newsroom: Health Sciences - July 10, 2014 Category: Universities & Medical Training Source Type: news

The impact of seat belts and airbags on high grade renal injuries and nephrectomy rates in motor vehicle collisions - Bjurlin MA, Fantus RJ, Mellett MM, Fantus RJ, Villines D.
PURPOSE: Motor vehicle collisions (MVCs) are the most common cause of blunt genitourinary trauma. We compared renal injuries with no protective device to those with seat belts and/or airbags utilizing the National Trauma Data Bank (NTDB). Our primary endpo... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - May 24, 2014 Category: Global & Universal Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Neurologic status at surgery affects metastatic spinal renal cell carcinoma survival
Neurological status at surgery, the grade of the original nephrectomy specimen and activity of the systemic disease were factors found to influence a patient’s survival after spine surgery for metastatic spinal renal cell carcinoma...02/28/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 28, 2014 Category: Cancer & Oncology Source Type: news

Partial nephrectomy may offer younger renal cancer patients survival advantage
Overall survival at 10 years was 94.0% with nephron-sparing surgery and 89.7% with radical nephrectomy, with a hazard ratio of 0.50.02/26/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 26, 2014 Category: Cancer & Oncology Source Type: news

Partial nephrectomy may offer younger renal cancer patients survival advantage
Partial nephrectomy may offer younger patients with localized renal cancer a distinct survival advantage compared with the complete removal of the kidney, US research suggests. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - February 24, 2014 Category: Cancer & Oncology Source Type: news

Partial nephrectomy may offer younger renal cancer patients survival advantage
Partial nephrectomy may offer younger patients with localized renal cancer a distinct survival advantage compared with the complete removal of the kidney, US research suggests. (Source: MedWire News - Urology)
Source: MedWire News - Urology - February 24, 2014 Category: Urology & Nephrology Source Type: news

Comparison of Outcomes After Minimally Invasive Versus Open Partial Nephrectomy
Complication rates of open partial nephrectomies (OPN) and minimally invasive partial nephrectomies (MIPN) have largely been reported by single and multi-institutional tertiary care centers.01/24/2014 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 24, 2014 Category: Cancer & Oncology Source Type: news

Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy
(Henry Ford Health System) Patients with chronic kidney disease who received robot-assisted partial nephrectomy to treat kidney cancer have minimal loss of kidney function -- a smaller amount even than patients with normal kidney function, according to researchers at Henry Ford Hospital's Vattikuti Urology Institute. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2014 Category: Cancer & Oncology Source Type: news

QoL Measures Between Partial vs Radical Nephrectomy in RCCQoL Measures Between Partial vs Radical Nephrectomy in RCC
How do quality of life measures differ between these two surgical groups? BMC Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 2, 2013 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Minimally invasive surgical techniques increasing for pediatric kidney patients
More children, like adults, are undergoing minimally invasive surgery for diseased kidneys, with most of the procedures being performed at teaching hospitals to treat non-cancerous conditions.Those conclusions were reached in a unique study by researchers at Henry Ford Hospital who set out to fill a knowledge gap about the use of nephrectomy - the surgical removal of a diseased kidney - in the U.S. pediatric population. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 28, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news